Vaccination with tumor peptide in CpG adjuvant protects via IFN-gamma-dependent CD4 cell immunity. (Q52012322)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2002

edit

Language	Label	Description	Also known as
English	Vaccination with tumor peptide in CpG adjuvant protects via IFN-gamma-dependent CD4 cell immunity.	scientific article published in June 2002

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

title

Vaccination with tumor peptide in CpG adjuvant protects via IFN-gamma-dependent CD4 cell immunity. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

author name string

Britta V Stern

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

Bernhard O Boehm

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

Magdalena Tary-Lehmann

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

language of work or name

English

0 references

publication date

1 June 2002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

published in

Journal of Immunology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

volume

168

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

issue

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

page(s)

6099-6105

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

cites work

Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism

1 reference

stated in

COCI

retrieved

24 May 2022

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1084/JEM.162.6.1745

Identifiers

DOI

10.4049/JIMMUNOL.168.12.6099

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

PubMed publication ID

12055220

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12055220

retrieved

19 April 2018

reference URL

http://europepmc.org/abstract/MED/12055220

ResearchGate publication ID

11319005

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52012322&oldid=2152682356"